GlassScriptPhysician profile
Bridgett Green
NPI 1548633761
$2,759.82
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,434 · 2022: $721 · 2023: $418 · 2024: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,049.21 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $948.33 | 2021-2023 | Xifaxan, Plenvu, Trulance |
| Gilead Sciences, INC. | $218.11 | 2021-2024 | Epclusa |
| Novo Nordisk INC | $149.27 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $87.15 | 2021-2023 | Linzess |
| Daiichi Sankyo INC. | $72.88 | 2021-2022 | |
| Janssen Biotech, INC. | $52.41 | 2023 | Stelara |
| Pfizer INC. | $37.79 | 2023 | |
| Intercept Pharmaceuticals, INC. | $29.94 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.06 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.70 | 2024 | Nuzyra |
| Evoke Pharma, INC. | $17.12 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.24 | 2021 | |
| Qol Medical, LLC | $16.07 | 2021 | |
| Celgene Corporation | $14.31 | 2023 | Zeposia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgett Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.